Pretreatment platelet-lymphocyte ratio is an independent predictor of cervical cancer recurrence following concurrent chemoradiation therapy

Author：                    

Publisher： Science Publishers

ISSN： 2049-9450

Source： Molecular and Clinical Oncology, Vol.3, Iss.5, 2015-01, pp. : 1001-1006

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Elevated Topoisomerase I Activity in Cervical Cancer as a Target for Chemoradiation Therapy

By Chen B.-M.   Chen J.-Y.   Kao M.   Lin J.-B.   Yu M.-H.   Roffler S.R.  

Gynecologic Oncology, Vol. 79, Iss. 2, 2000-11 ,pp. : 272-280

Elsevier

Access to resources Recommend Favorite

Analysis of the Cost Effectiveness of Concurrent Cisplatin-Based Chemoradiation in Cervical Cancer: Implications from Five Randomized Trials

By Rose P.G.   Lappas P.T.  

Gynecologic Oncology, Vol. 78, Iss. 1, 2000-07 ,pp. : 3-6

Elsevier

Access to resources Recommend Favorite

Adjuvant chemotherapy following concurrent chemoradiotherapy for uterine cervical cancer with lymphadenopathy

By          

Oncology Letters, Vol. 3, Iss. 3, 2012-01 ,pp. : 571-576

Spandidos Publications

Access to resources Recommend Favorite

Technical Feasibility of Laparoscopic Lateral Pelvic Lymph Node Dissection for Patients with Low Rectal Cancer after Concurrent Chemoradiation Therapy

By Liang Jin-Tung  

Annals of Surgical Oncology, Vol. 18, Iss. 1, 2011-01 ,pp. : 153-159

Springer Publishing Company

Access to resources Recommend Favorite

Is Final TNM Staging A Predictor for Survival in Locally Advanced Rectal Cancer after Preoperative Chemoradiation Therapy?

By Kuo Li-Jen  

Annals of Surgical Oncology, Vol. 14, Iss. 10, 2007-10 ,pp. : 2766-2772

Springer Publishing Company

Access to resources Recommend Favorite